Hester Biosciences Limited (BOM:524669)

Hester Biosciences Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Revenue	3,002	3,111	3,045	2,661	2,350	2,143
Other Revenue	103.5	13.72	66.48	121.14	116.41	33.64
Revenue	3,106	3,125	3,112	2,782	2,466	2,177
Revenue Growth (YoY)	-1.85%	0.41%	11.86%	12.80%	13.30%	15.94%
Cost of Revenue	866.62	928.37	997.28	824.81	678.19	527.1
Gross Profit	2,239	2,196	2,115	1,957	1,788	1,650
Selling, General & Admin	717.4	728.49	752.69	675.39	516.02	440.33
Other Operating Expenses	830.41	843.64	758.94	654.62	536.16	478.27
Operating Expenses	1,718	1,740	1,683	1,537	1,238	1,059
Operating Income	521.21	456.22	431.29	420.28	550.43	591.22
Interest Expense	-14.62	-83.4	-91.19	-51.49	-25.76	-60.62
Interest & Investment Income	20.37	20.37	19.07	21.73	19.03	12.94
Earnings From Equity Investments	54.86	41	46.09	44.09	4.23	-
Currency Exchange Gain (Loss)	-33.62	-33.62	-94.68	-29.92	-4.59	-4.03
Other Non Operating Income (Expenses)	-4.86	-4.86	-3.1	-3.31	-9.57	-5.42
EBT Excluding Unusual Items	543.34	395.71	307.48	401.38	533.77	534.09
Gain (Loss) on Sale of Assets	-	-	0.28	0.16	1.25	0.15
Other Unusual Items	-	-	11.77	-	-	-33.21
Pretax Income	543.34	395.71	319.53	401.54	535.02	501.03
Income Tax Expense	97.58	107.45	107.87	121.19	140.18	154.05
Earnings From Continuing Operations	445.76	288.26	211.66	280.35	394.84	346.98
Minority Interest in Earnings	-7.32	-13.38	-22.77	-14.08	-1.64	-2.68
Net Income	438.44	274.88	188.89	266.27	393.2	344.3
Net Income to Common	438.44	274.88	188.89	266.27	393.2	344.3
Net Income Growth	86.82%	45.52%	-29.06%	-32.28%	14.20%	18.03%
Shares Outstanding (Basic)	9	9	9	9	9	9
Shares Outstanding (Diluted)	9	9	9	9	9	9
Shares Change (YoY)	3.58%	-	-	-	-	-
EPS (Basic)	50.01	32.31	22.20	31.30	46.22	40.47
EPS (Diluted)	50.01	32.31	22.20	31.30	46.22	40.47
EPS Growth	80.36%	45.52%	-29.06%	-32.28%	14.20%	18.03%
Free Cash Flow	419.01	439.2	237.86	-541.66	-869.98	173.11
Free Cash Flow Per Share	47.80	51.63	27.96	-63.67	-102.27	20.35
Dividend Per Share	-	7.000	6.000	8.000	10.000	10.000
Dividend Growth	-	16.67%	-25.00%	-20.00%	-	51.52%
Gross Margin	72.10%	70.29%	67.95%	70.35%	72.50%	75.79%
Operating Margin	16.78%	14.60%	13.86%	15.11%	22.32%	27.16%
Profit Margin	14.12%	8.80%	6.07%	9.57%	15.94%	15.82%
Free Cash Flow Margin	13.49%	14.06%	7.64%	-19.47%	-35.27%	7.95%
EBITDA	687.39	620.39	599.98	624.22	712.92	720.33
EBITDA Margin	22.13%	19.85%	19.28%	22.44%	28.90%	33.09%
D&A For EBITDA	166.18	164.17	168.69	203.94	162.49	129.11
EBIT	521.21	456.22	431.29	420.28	550.43	591.22
EBIT Margin	16.78%	14.60%	13.86%	15.11%	22.32%	27.16%
Effective Tax Rate	17.96%	27.15%	33.76%	30.18%	26.20%	30.75%
Revenue as Reported	3,131	3,150	3,152	2,812	2,487	2,190
Advertising Expenses	-	77.73	88.06	99.74	49.63	37.96

Source: S&P Global Market Intelligence. Standard template. Financial Sources.